Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: Murray_Mac who wrote (1478)	5/2/2000 5:37:00 PM
From: Murray_Mac	Respond to of 3392

CYBR the next billion dollar maker How Truthseeker or Auric can argue these facts and opinion from Mozerd is beyond me....... Its my personal belief that Unequivocally, CYBR is the best LTBH investment money can buy bar none. Each link provided below is in support of my enthusiasm and validation for this undervalued equity and for your reference. resourceLink of Iowa Reports Success in Reducing Health Care Costs using CYBeR-CARE'S Electronic Housecall System moneycentral.msn.com Dr. Michael Kienzle, Director of Telemedicine for the University of Iowa Health Care, states "We are seeing significant benefits both in terms of cost and clinical outcomes. In fact, based on a 2-year study that will soon be released, overall health care costs related to patients in the study have been reduced by as much as 36%." Considering CYBR and its prospects for the future you may be interested to note that CYBR's strategic alliances with Nortel, the Mayo Clinic, ING Baring, Georgia Tech, the Medical College of Georgia, SIIC, Metropolitan Health Networks Inc, and others to be announced soon, together with CYBR's patents and leadership, differentiate it from all competitors in the emerging telemedicine field. CYBR will dominate telemedicine like CISCO, MSFT, INTC and ORCL dominate their respective markets. And here's why: Take the time to read these links Stocks to Watch askmen.com Taylor Stuart Financial biz.yahoo.com Connecticut Capital Markets biz.yahoo.com Tech Talk: Cyber-Care's Remote Monitoring Solution xceedintelligence.com Interview with David Wanetick ragingbull.com Agreement With ING Barings biz.yahoo.com Shanghai Medical Sign Joint Venture biz.yahoo.com Nortel Networks and CyberCare nortelnetworks.com Future of Telemeicine ragingbull.com 1st USA Manufacturer (Colin Medical Instruments, ISO 9001 certified) moneycentral.msn.com Up Close with Cyber-Care: CEO Mike Morrell telemedicineindex.com./opinions/interviews.asp ORCL, SAP, SUNW, JDSU, etc. are, as you say, "quality" investments. But if you study their history, you will quickly see that each of them (with the exception of SAP which was in the BIG German money from the start), had modest beginnings. CYBR is a giant in the making. Once FDA approval is received (imminent), there will be no turning back. Valuations of $52 will be low. Present day valuations of $52 are already low. CYBR's trading range is $0.65 - $40.00 Small caps become mid-caps become large caps. Not overnight. But it happens every day. CYBR is on the fast track to mid-cap status. Can large cap status be far behind? For quality info the following links will be helpful Cyber-Care History ---------------- ragingbull.com Where is CyberCare headed?-- ragingbull.com BSP?s EBITDA model ------------ ragingbull.com Contract progress review -------- ragingbull.com Straight talk on share dilution --- ragingbull.com ..DM.. National Market listing announcement moneycentral.msn.com NOTE: Nasdaq National Market status The Nasdaq National Market nasdaq.com As the market for Nasdaq's largest and most actively traded securities, the Nasdaq National Market lists more than 4,400 securities. To be listed on the National Market, a company must satisfy stringent financial, capitalization, and corporate governance standards. Nasdaq National Market companies include some of the largest, best known companies in the world. (Voluntary Disclosure: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy)